InvestorsHub Logo
Followers 44
Posts 4595
Boards Moderated 0
Alias Born 07/19/2006

Re: DewDiligence post# 874

Thursday, 05/23/2019 1:35:12 PM

Thursday, May 23, 2019 1:35:12 PM

Post# of 7785
It would seem a bit at odds though if EQT were to license daxi for therapeutic indications while owning dysport - a competitor to daxi - for consmetic indications. IF EQT wants daxi for cosmetic to promote a long acting and short acting that probably wouldn't be ideal since there would be some conflict and daxi promotion might suffer.
So I'm having a hard time seeing them as a partner for revance unless they drop dysport
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News